1. Breast cancer management with CDK4/6 inhibitors as first line treatment: a single institution retrospective review. (November 2022) Authors: Villa, F.; Corbetta, C.; Crippa, A.; Pelizzoni, D.; Vittimberga, I.; Sansi, C.; Arnoffi, J.; Guida, F.M.; Cuomo, O.; Tafuni, M.; Sassone, M.C.; Viganò, C.V.; Anghilieri, M.; Ardizzoia, A. Journal: European journal of cancer Issue: Volume 175(2022)Supplement 1 Page Start: S69 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Evaluation of dexamethasone (DEX)-sparing regimens, administered with NEPA, a fixed combination of netupitant and palonosetron, for the prevention of chemotherapy-induced nausea and vomiting (CINV) in older patients receiving high-dose cisplatin. (December 2021) Authors: Celio, L.; Cortinovis, D.; Cogoni, A.A.; Cavanna, L.; Martelli, O.; Carnio, S.; Collovà, E.; Bertolini, F.; Petrelli, F.; Cassano, A.; Chiari, R.; Zanelli, F.; Pisconti, S.; Vittimberga, I.; Letizia, A.; Misino, A.; Gernone, A.; Bonizzoni, E.; Pilotto, S.; De Placido, S. Journal: Journal of geriatric oncology Issue: Volume 12(2021)Supplement 1 Page Start: S18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗